Ozempic Prices Are Soaring-Experts Reveal 5 Ways to Save on GLP-1 Meds Not long ago, the FDA announced there's no longer a shortage of Ozempic, Wegovy, Zepbound or similar drugs used for weight loss.

Recently, scientific studies show that Ozempic/Wegovy and other GLP-1 drugs can also cause vision loss through an eye injury called non-arteritic anterior ischemic optic neuropathy (“ NAION ”).

A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition By Annika Kim Constantino, CNBC and Ashley Capoot, CNBC • Published June 11, 2025 • Updated on June 11, 2025 at 1 ...

Ozempic and Wegovy generated combined sales of DKK 50.1 billion in the first quarter of 2025, accounting for around 66% of the company’s total revenues.

It spent $4.6 billion on Ozempic in 2022, compared with $2.6 billion the year before, according to KFF. Another KFF analysis found that Wegovy could cost Medicare nearly $3 billion a year.

Ozempic and other so-called “miracle” weight-loss meds are being prescribed to teens in record numbers, with prescriptions among 12- to 17-year-olds jumping 50% in 2024, according to Truveta.

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s Disruptor 50 List.

Ozempic generated DKK 32.7 billion (up 15%), while Wegovy generated DKK 17.4 billion (up 83%) in sales in the first quarter of 2025. The combined figure accounted for around 66% of the company’s ...